Suchergebnisse - "Humpe, Andreas"

PubPharm (81)

11

A novel Fc-optimized antibody drug conjugate targeting CD7 as a therapeutic strategy in T-cell acute lymphoblastic leukemia

enthalten in: Blood | 2023

von Gehlert, C. | Schewe, D. | Klausz, K. | +18

12

ATMPs : New Challenge for Transfusion Services

enthalten in: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2022

von Frey, B. | Humpe, A.

13

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen

enthalten in: Biological chemistry | 2022

von Kellner, C. | Lutz, S. | Oberg, H. | +13

14

Emergency Use of Convalescent Plasma : Perception of the Regulatory Framework from a Clinical Perspective

enthalten in: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2022

von Möhnle, P. | Humpe, A. | Boeck, M. | +4

15

Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses

enthalten in: Nature methods | 2022

von Albanese, M. | Ruhle, A. | Mittermaier, J. | +12

CommentIn: Nat Methods. 2022 Jan;19(1):36-37. - PMID 34949808

16

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

enthalten in: Frontiers in immunology | 2022

von Zeller, T. | Lutz, S. | Münnich, I. | +18

17

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen

enthalten in: Biological chemistry | 2021

von Kellner, C. | Lutz, S. | Oberg, H. | +13

18

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen

enthalten in: Biological chemistry | 2021

von Kellner, C. | Lutz, S. | Oberg, H. | +13

19

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

enthalten in: Journal of hematology & oncology | 2021

von Tahk, S. | Vick, B. | Hiller, B. | +12

20

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

enthalten in: Journal of hematology & oncology | 2021

von Tahk, S. | Vick, B. | Hiller, B. | +12